北方药学
北方藥學
북방약학
JOURNAL OF NORTH PHARMACY
2015年
5期
18-18,19
,共2页
刘华春%唐阳峰%陈新华%杨根
劉華春%唐暘峰%陳新華%楊根
류화춘%당양봉%진신화%양근
挤压综合征%肾功能%血必净注射液
擠壓綜閤徵%腎功能%血必淨註射液
제압종합정%신공능%혈필정주사액
crush syndrome%Renal function%Xuebijing Injection
目的:观察血必净注射液对挤压综合征并肾功能衰竭的临床治疗效果。方法:将28例挤压综合征并肾功能衰竭患者随机分为两组,每组14例。对照组给予常规内外科治疗,观察组在对照组基础上注射血必净。治疗前后监测两组肾功能指标水平,并观察两组疗效。结果:治疗后,两组尿量提升至正常水平,24h UP、SCr、BUN、血β2-MG水平明显降低(P<0.05),观察组24h UP、SCr、BUN、血β2-MG水平显著低于对照组(P<0.05)。观察组总有效率为92.9%,显著高于对照组的78.6%(P<0.05)。结论:血必净注射液可以明显提高挤压综合征并肾功能衰竭的治疗效果,降低死亡率,值得临床推广。
目的:觀察血必淨註射液對擠壓綜閤徵併腎功能衰竭的臨床治療效果。方法:將28例擠壓綜閤徵併腎功能衰竭患者隨機分為兩組,每組14例。對照組給予常規內外科治療,觀察組在對照組基礎上註射血必淨。治療前後鑑測兩組腎功能指標水平,併觀察兩組療效。結果:治療後,兩組尿量提升至正常水平,24h UP、SCr、BUN、血β2-MG水平明顯降低(P<0.05),觀察組24h UP、SCr、BUN、血β2-MG水平顯著低于對照組(P<0.05)。觀察組總有效率為92.9%,顯著高于對照組的78.6%(P<0.05)。結論:血必淨註射液可以明顯提高擠壓綜閤徵併腎功能衰竭的治療效果,降低死亡率,值得臨床推廣。
목적:관찰혈필정주사액대제압종합정병신공능쇠갈적림상치료효과。방법:장28례제압종합정병신공능쇠갈환자수궤분위량조,매조14례。대조조급여상규내외과치료,관찰조재대조조기출상주사혈필정。치료전후감측량조신공능지표수평,병관찰량조료효。결과:치료후,량조뇨량제승지정상수평,24h UP、SCr、BUN、혈β2-MG수평명현강저(P<0.05),관찰조24h UP、SCr、BUN、혈β2-MG수평현저저우대조조(P<0.05)。관찰조총유효솔위92.9%,현저고우대조조적78.6%(P<0.05)。결론:혈필정주사액가이명현제고제압종합정병신공능쇠갈적치료효과,강저사망솔,치득림상추엄。
Objective:To investigate the efficacy of Xuebijing injection in the treatment of crush syndrome and renal failure. Methods: 28 cases of crush syndrome and renal failure were randomly divided into two groups, 14 cases in each group. The control group was given conventional surgical treatment,and observation group was given Xuebijing injection based on control group. Before and after treatment, renal function levels of groups were detected, and the efficacy of two groups were observed. Results:After treatment,the 24h UP, SCr, BUN, serum β2-MG levels of two groups were significantly reduced (P<0.05),and 24h UP, SCr, BUN, serum β2-MG levels of observation group were significantly lower than control group (P<0.05). The total effective rate of observation group was 92.9%, which was significantly higher than control group(78.6%)(P<0.05). Conclusion: Xuebijing injection can significantly improve the efficacy of the crush syndrome and renal failure, reducing mortality, worthy of clinical application.